HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ian Walters Selected Research

Combination Drug Therapy (Combination Chemotherapy)

7/2013Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type K-RAS colorectal carcinoma: the NCIC Clinical Trials Group and AGITG CO.20 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ian Walters Research Topics

Disease

8Neoplasms (Cancer)
11/2021 - 04/2012
7Hepatocellular Carcinoma (Hepatoma)
01/2017 - 04/2011
3Hypertension (High Blood Pressure)
10/2013 - 04/2011
3Fatigue
10/2013 - 04/2011
2Fibrosis (Cirrhosis)
01/2015 - 01/2014
2Colorectal Neoplasms (Colorectal Cancer)
01/2014 - 07/2013
2Hyponatremia
10/2013 - 10/2013
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2019
1Sarcoma (Soft Tissue Sarcoma)
10/2019
1Breast Neoplasms (Breast Cancer)
10/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1Transitional Cell Carcinoma
10/2019
1Ovarian Neoplasms (Ovarian Cancer)
10/2019
1Glioblastoma (Glioblastoma Multiforme)
02/2015
1Liver Neoplasms (Liver Cancer)
01/2014
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2014
1Carcinogenesis
10/2013
1Diarrhea
04/2011

Drug/Important Bio-Agent (IBA)

11brivanibIBA
10/2019 - 04/2011
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 04/2012
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2014 - 10/2013
2Cetuximab (Erbitux)FDA Link
01/2014 - 07/2013
2Sorafenib (BAY 43-9006)FDA Link
10/2013 - 10/2013
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
06/2012 - 04/2012
1AntigensIBA
11/2021
1EpitopesIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2019
1Cytotoxins (Cytolysins)IBA
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2017
1Fibronectins (Fibronectin)IBA
02/2015
1CT-322IBA
02/2015
1Biological ProductsIBA
02/2015
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
02/2015
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2014
1Carbon Tetrachloride (Tetrachloromethane)IBA
01/2014
1CollagenIBA
01/2014
1Phosphotransferases (Kinase)IBA
01/2014
1Thioacetamide (Thioacetamid)IBA
01/2014
1Tyrosine (L-Tyrosine)FDA Link
01/2014
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2014
1Growth Factor ReceptorsIBA
07/2013
1Monoclonal AntibodiesIBA
07/2013
1ProdrugsIBA
06/2012
1thiamine triphosphorate (TTP)IBA
04/2012

Therapy/Procedure

5Therapeutics
01/2019 - 04/2011
2Drug Therapy (Chemotherapy)
01/2014 - 07/2013
1Immunotherapy
11/2021
1Aftercare (After-Treatment)
01/2019
1Ligation
01/2014
1Combination Drug Therapy (Combination Chemotherapy)
07/2013